Studies on anti-inflammatory effects of an injectable copolymer of fatty acids (Ara 3000 betaÃÂ®)Baugé C1,2*, Beck C3, Devaux E3, Ewert G3 and Boumediene K1,2
- *Corresponding Author:
- Baugé C
Université de Caen Normandie, France
Tel: +33 231068218
Fax: +33 231068224
Email: [email protected]
Received date: December 04, 2015 Accepted date: January 15, 2016 Published date: January 27, 2016
Citation:Baugé C, Beck C, Devaux E, Ewert G and Boumediene K (2016) Studies on Anti-inflammatory effects of an Injectable Copolymer of Fatty acids (Ara 3000 beta®). J Ost Arth 1:102. doi: 10.4172/joas.1000102
Copyright: © 2016 Baugé C. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Osteoarthritis (OA) is the most common musculoskeletal disease. It is a long-term chronic disease involving the thinning of cartilage in joints which results in bones rubbing together, creating stiffness, pain, and impaired movement. The current control strategy mainly consists in palliative pain treatment, and there are several medicines on the market that alleviate pain and improve function in OA patients. The identification of new therapeutic drugs or procedures could improve the patient quality of life. Recently, the benefice of fatty acids has emerged. In particular, our work published in Journal of Inflammation highlights, by in vitro and in vivo experiments, the anti-inflammatory effects of an injectable copolymer of fatty acid (Ara 3000 beta®) in joints.